Detalles de la búsqueda
1.
Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive-Stage Small Cell Lung Cancer.
Oncologist
; 25(11): 981-992, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32860288
2.
A Population-Based Study of Complications After Colorectal Surgery in Patients Who Have Received Bevacizumab.
Dis Colon Rectum
; 61(3): 306-313, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29420426
3.
Neoadjuvant hyperfractionated chemoradiation and liver transplantation for unresectable perihilar cholangiocarcinoma in Canada.
J Surg Oncol
; 117(2): 213-219, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29480952
4.
A final report of a phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis with a dose escalation in ovarian and fallopian tube cancers.
Gynecol Oncol
; 144(3): 486-490, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28109627
5.
Veliparib in combination with whole brain radiation therapy in patients with brain metastases: results of a phase 1 study.
J Neurooncol
; 122(2): 409-17, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25682091
6.
Follow-Up Imaging Guidelines for Patients with Stage III Unresectable NSCLC: Recommendations Based on the PACIFIC Trial.
Curr Oncol
; 30(4): 3817-3828, 2023 03 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37185402
7.
Palliative Radiation for Advanced Central Lung Tumors With Intentional Avoidance of the Esophagus (PROACTIVE): A Phase 3 Randomized Clinical Trial.
JAMA Oncol
; 8(4): 1-7, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35201290
8.
A dose-escalation phase I trial of nimotuzumab, an antibody against the epidermal growth factor receptor, in patients with advanced solid malignancies.
Invest New Drugs
; 29(5): 996-1003, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20454832
9.
A Canadian Perspective on the Challenges for Delivery of Curative-Intent Therapy in Stage III Unresectable Non-Small Cell Lung Cancer.
Curr Oncol
; 28(3): 1618-1629, 2021 04 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33923355
10.
Stereotactic body radiation therapy for hepatocellular carcinoma with Macrovascular invasion.
Radiother Oncol
; 156: 120-126, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33285195
11.
Radiation recall dermatitis triggered by multi-targeted tyrosine kinase inhibitors: sunitinib and sorafenib.
Anticancer Drugs
; 21(2): 206-9, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19952730
12.
Radiation dose for thymic tumours.
Mediastinum
; 4: 35, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-35118303
13.
Applicability of the PACIFIC trial results in patients not eligible for the PACIFIC trial: Canadian rapid consensus statement and recommendations.
Cancer Treat Res Commun
; 25: 100265, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33310367
14.
Long term outcomes of stereotactic body radiation therapy for hepatocellular carcinoma without macrovascular invasion.
Eur J Cancer
; 134: 41-51, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32460180
15.
Immune checkpoint-inhibitors and chemoradiation in stage III unresectable non-small cell lung cancer.
Lung Cancer
; 134: 259-267, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31319991
16.
Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival in Patients Treated With Lung Stereotactic Body Radiation Therapy (SBRT).
Clin Lung Cancer
; 19(2): e219-e226, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29066051
17.
Radiation Therapy Quality Assurance (RTQA) of Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer in the PROCLAIM Phase 3 Trial.
Int J Radiat Oncol Biol Phys
; 101(4): 927-934, 2018 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29976505
18.
Translation of Knowledge to Practice-Improving Awareness in NSCLC Molecular Testing.
J Thorac Oncol
; 13(7): 1004-1011, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29535011
19.
The ongoing challenge of large anal cancers: prospective long term outcomes of intensity-modulated radiation therapy with concurrent chemotherapy.
Oncotarget
; 9(29): 20439-20450, 2018 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-29755663
20.
Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemcitabine for locally advanced unresectable or resected pancreatic cancer: a phase I-II study.
Int J Radiat Oncol Biol Phys
; 67(4): 1027-36, 2007 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17197132